Search results for " carbohydrate"

showing 10 items of 126 documents

Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen.

2011

A novel MUC1-glycopeptide–BSA conjugate vaccine with a specifically fluorinated Thomsen–Friedenreich antigen side chain at Thr6 was prepared. Preliminary immunological experiments reveal specific binding of the tumor-associated glycopeptide antigen analog by anti-MUC1-mouse antibodies.

digestive systemCatalysisMiceAntigenConjugate vaccineMaterials ChemistryAnimalsAntigens Tumor-Associated Carbohydrateskin and connective tissue diseasesneoplasmsMUC1Vaccines ConjugatebiologyThomsen-Friedenreich AntigenChemistryMucin-1Metals and AlloysGlycopeptidesSerum Albumin BovineGeneral ChemistryMolecular biologybiological factorsdigestive system diseasesGlycopeptideSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsCeramics and Compositesbiology.proteinCattleAntibodyChemical communications (Cambridge, England)
researchProduct

Conversion of carbohydrates into 5-HMF in Deep Eutectic Solvents under mild reaction conditions

Deep eutectic solvents carbohydrate conversion 5-hydroxymethylfurfural biomass valorization environmental friendly processSettore CHIM/06 - Chimica Organica
researchProduct

Suitability of non-glucose-carbohydrates for parenteral nutrition

1975

Postoperative parenteral nutrition can only be optimally effective if the characteristics of post-traumatic metabolism are taken into account. Two main possibilities are discussed for the carbohydrate component of parenteral nutrition during this phase: glucose with high doses of insulin or non-glucose carbohydrates (sugar substitutes) possibly in a suitable combination with glucose. The risks as well as the technical and organisational problems involved in the use of them are discussed and the authors prefer the second of the two alternatives. Possible side effects of non-glucose carbohydrates are pointed out and it is shown how these can be avoided by observing dose guidelines. So far a c…

Parenteral Nutritionmedicine.medical_treatmentBlood sugarPhysiologyFructoseCarbohydrate metabolismCritical Care and Intensive Care MedicineXylitolElectrolyteschemistry.chemical_compoundPregnancyDietary CarbohydratesmedicineHumansSugarXylitolOxalatesAdenine Nucleotidesbusiness.industryInsulinProteinsBilirubinGeneral MedicineMetabolismCarbohydrateLipid MetabolismUric AcidGlucoseParenteral nutritionBiochemistrychemistryLactatesFemaleParenteral Nutrition TotalbusinessEuropean Journal of Intensive Care Medicine
researchProduct

[The ketogenic diet: an underappreciated therapeutic option?].

2011

Obesity is reaching epidemic proportions in Western countries and is a strong risk factor for cardiovascular disease. Despite the constant recommendations of health care organizations regarding the importance of weight control, this goal often fails. Although there is a common agreement about the concept that exercise and diet are two key factors for the control of body weight, the ideal amount and type of exercise and also the ideal diet for weight control are still under debate. A widely accepted nutritional regime is the Mediterranean diet that has evident health benefits although less attention has been paid to see if the effects are due to other lifestyle factors which may contribute t…

Diet ReducingKetogenic diet dietary habits lifestyleKetone BodiesDiet MediterraneanDiet Carbohydrate-RestrictedAdipose TissueCardiovascular DiseasesRisk FactorsWeight LossDietary CarbohydratesHumansHydroxymethylglutaryl CoA ReductasesObesityDiet KetogenicEnergy Metabolism
researchProduct

Sweeteners and sweetness enhancers

2017

indexation en cours; PURPOSE OF REVIEW: The current review summarizes and discusses current knowledge on sweeteners and sweetness enhancers. RECENT FINDINGS: The perception of sweet taste is mediated by the type 1 taste receptor 2 (T1R2)/type 1 taste receptor 3 (T1R3) receptor, which is expressed in the oral cavity, where it provides input on the caloric and macronutrient contents of ingested food. This receptor recognizes all the compounds (natural or artificial) perceived as sweet by people. Sweeteners are highly chemically diverse including natural sugars, sugar alcohols, natural and synthetic sweeteners, and sweet-tasting proteins. This single receptor is also the target for developing …

0301 basic medicineobesitysweetener[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionreceiverMedicine (miscellaneous)PharmacologyOral cavityReceptors G-Protein-Coupled03 medical and health sciencesSugar AlcoholsTaste receptorgoût sucréDietary CarbohydratesAnimalsHumansSteviaMedicinesweet taste receptorNutrition and Dieteticsbusiness.industrydigestive oral and skin physiologyTaste Perceptionfood and beveragesSweet tasteSweetnessobésité030104 developmental biologycarbohydrateSweetening AgentsTastebusinessrécepteur[SDV.AEN]Life Sciences [q-bio]/Food and Nutritiondiabète
researchProduct

Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted An…

2010

Breast NeoplasmsCancer VaccinesAntibodiesCatalysisMiceCell Line TumorTetanus ToxoidmedicineAnimalsHumansAntigens Tumor-Associated CarbohydrateMUC1Vaccines SyntheticThomsen-Friedenreich AntigenChemistryTetanusMucin-1GlycopeptidesToxoidFluorineGeneral ChemistryFlow Cytometrymedicine.diseaseGlycopeptideBiochemistryFemaleConjugateAngewandte Chemie International Edition
researchProduct

Tuning tumor-specific T-cell activation: a matter of costimulation?

2002

Abstract The stimulation of a specific antitumor immune response, involving the recruitment of T cells and induction of T-cell effector functions, is an attractive possibility for cancer immunotherapy. In the past few years, advances in our understanding of the mechanisms of T-cell activation and costimulation have provided the basis for strategies to enhance antitumor immunity and break tolerance. These strategies include the equipment of tumor cells with costimulatory molecules such as B7, blockade of inhibitory signals on T cells (e.g. through cytotoxic T-lymphocyte antigen 4) and grafting of T cells with antigen-triggered, recombinant costimulatory receptors. Combining antigen-triggered…

ImmunoconjugatesT cellmedicine.medical_treatmentT-LymphocytesImmunologyBiologyLymphocyte ActivationImmunotherapy AdoptiveAbataceptCancer immunotherapyCD28 AntigensAntigens CDNeoplasmsmedicineImmunology and AllergyCytotoxic T cellHumansAntigens Tumor-Associated CarbohydrateCTLA-4 AntigenIL-2 receptorAntigen-presenting cellCD28ImmunotherapyAntigens Differentiationmedicine.anatomical_structureCTLA-4ImmunologyB7-1 AntigenTrends in immunology
researchProduct

Effects of streptozotocin and dietary fructose on delta-6 desaturation in spontaneously hypertensive rat liver.

2004

We have investigated the effects of hypertension associated with diabetes mellitus on polyunsaturated fatty acid biosynthesis. For this purpose, two rat models for these pathologies have been established: a type 1 diabetic hypertensive model obtained by streptozotocin injection to spontaneously hypertensive rat (SHR), followed or not by insulin treatment (experiment 1); a type 2 diabetic hypertensive model by feeding SHR with a fructose enriched diet (experiment 2). Liver gene expression of delta-6 desaturase (D6D), microsomal D6D activities and fatty acid composition of total lipids were estimated. In experiment 1, an increase of linoleic acid (18:2 n-6) level was observed in the streptozo…

Malemedicine.medical_specialtymedicine.medical_treatmentType 2 diabetesFructoseBiochemistryGene Expression Regulation EnzymologicStreptozocinchemistry.chemical_compoundSpontaneously hypertensive ratInternal medicineDiabetes mellitusMicrosomesRats Inbred SHRmedicineDietary CarbohydratesAnimalsHumansInsulinInsulinFatty AcidsFructoseGeneral Medicinemedicine.diseaseStreptozotocinDietRatsDisease Models AnimalEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2LiverLipogenesisHypertensionFatty Acids UnsaturatedMetabolic syndromeStearoyl-CoA Desaturasemedicine.drugBiochimie
researchProduct

Towards a fully synthetic MUC1-based anticancer vaccine: efficient conjugation of glycopeptides with mono-, di-, and tetravalent lipopeptides using c…

2011

Abstract The membrane-bound tumor-associated glycoprotein MUC1 is aberrantly glycosylated in cancer cells compared with normal cells, and is therefore considered an attractive target for cancer immunotherapy. However, tumor-associated glycopeptides from MUC1 do not elicit a sufficiently robust immune response. Therefore, antitumor vaccines were developed, which consist of MUC1 glycopeptides as the B epitopes and immune-stimulating toll-like receptor 2 (TLR 2) lipopeptide ligands. These fully synthetic vaccine candidates were prepared by solid-phase synthesis of the MUC1 glycopeptides. The Pam(3) Cys lipopeptide, also synthesized on solid-phase, was C-terminally coupled to oligovalent lysine…

Synthetic vaccineMagnetic Resonance SpectroscopyCarbohydrate chemistryMolecular Sequence DataAntineoplastic AgentsCancer VaccinesCatalysisEpitopeCell Linechemistry.chemical_compoundLipopeptidesMiceSolid-phase synthesisAnimalsHumansAntigens Tumor-Associated CarbohydrateVaccines SyntheticMembrane GlycoproteinsMolecular StructureOrganic ChemistryMucin-1GlycopeptidesLipopeptideGeneral ChemistryCombinatorial chemistryGlycopeptidechemistryClick chemistryClick ChemistryConjugateProtein BindingChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure

2015

AIM:Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have emerged as robust prognostic biomarkers in heart failure. Experimental data have also suggested a potential molecular interaction between CA125 and Gal-3; however, the biological and clinical relevance of this interaction is still uncertain. We sought to evaluate, in patients admitted for acute heart failure, the association between plasma Gal-3 with all-cause mortality and the risk for rehospitalizations among high and low levels of CA125. METHODS AND RESULTS: We included 264 consecutive patients admitted for acute heart failure to the Cardiology Department in a third-level center. Both biomarkers were measured on admission. …

Maleendocrine system diseasesGalectin 3lcsh:MedicineRisk FactorsBlood plasmaANTIGEN CARBOHYDRATE 125lcsh:ScienceAged 80 and overMultidisciplinaryca125Mortality rateBlood Proteins//purl.org/becyt/ford/3.1 [https]Middle AgedPrognosisMedicina BásicaGalectin-3Female//purl.org/becyt/ford/3 [https]Research Articlemedicine.medical_specialtyCIENCIAS MÉDICAS Y DE LA SALUDcontributesGalectinsInmunologíaPatient ReadmissionAntigenInternal medicinemedicineHumanssurfaceClinical significanceIn patientIntensive care medicineAgedProportional Hazards ModelsHeart FailureGALECTIN-3business.industryProportional hazards modellcsh:Rassociationmedicine.diseaseACUTE HEART FAILUREstatin therapyinflammationCA-125 AntigenHeart failurecellslcsh:QbusinessBiomarkersFollow-Up Studies
researchProduct